These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16230180

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK.
    J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Preliminary study of diagnostic utility of molecular beacons in bladder cancer.
    Zhao J, Wang ZQ, Wang XY, Yang XJ, He D.
    Urology; 2010 Aug; 76(2):512.e8-13. PubMed ID: 20579701
    [Abstract] [Full Text] [Related]

  • 29. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I.
    Cancer; 2007 Dec 25; 111(6):517-24. PubMed ID: 17963263
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of seven screening methods in the diagnosis of bladder cancer.
    Sun Y, He DL, Ma Q, Wan XY, Zhu GD, Li L, Luo Y, He H, Yang L.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1763-71. PubMed ID: 17097029
    [Abstract] [Full Text] [Related]

  • 35. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.
    J Urol; 2006 Jul 05; 176(1):44-7. PubMed ID: 16753364
    [Abstract] [Full Text] [Related]

  • 36. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer].
    Imamura M, Inoue K, Megumi Y, Nishimura M, Ohmori K, Nishimura K.
    Hinyokika Kiyo; 2000 Oct 05; 46(10):705-9. PubMed ID: 11215195
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep 05; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 39. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R, Sinha T, Karan SC, Doddamani D, Sandhu A, Sethi GS, Srivastava A, Narang V, Agarwal A, Adhlakha N.
    Urology; 2007 Aug 05; 70(2):267-71. PubMed ID: 17826487
    [Abstract] [Full Text] [Related]

  • 40. [The application of BTA stat in the diagnosis of bladder tumor and hematuria].
    Wang X, Xu K, Zhu J, Hou S.
    Zhonghua Wai Ke Za Zhi; 1999 Apr 05; 37(4):228-30. PubMed ID: 11829827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.